dehydroepiandrosterone has been researched along with Bone Loss, Osteoclastic in 7 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erlandsson, MC | 1 |
| Bian, L | 1 |
| Jonsson, IM | 1 |
| Andersson, KM | 1 |
| Bokarewa, MI | 1 |
| Wang, YD | 1 |
| Wang, L | 1 |
| Li, DJ | 1 |
| Wang, WJ | 1 |
| Jayasinghe, Y | 1 |
| Grover, SR | 1 |
| Zacharin, M | 1 |
| McCarty, MF | 1 |
| Labrie, F | 1 |
| Diamond, P | 1 |
| Cusan, L | 1 |
| Gomez, JL | 1 |
| Bélanger, A | 1 |
| Candas, B | 1 |
| Scott, A | 1 |
| Higdon, K | 1 |
| Tucci, M | 1 |
| Benghuzzi, H | 1 |
| Puckett, A | 1 |
| Tsao, A | 1 |
| Cason, Z | 1 |
| Hughes, J | 1 |
| Taelman, P | 1 |
| Kaufman, JM | 1 |
| Janssens, X | 1 |
| Vermeulen, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of DHEA/Exercise on Bone, Muscle and Balance[NCT00664053] | Phase 4 | 99 participants (Actual) | Interventional | 2004-10-31 | Completed | ||
| Effect of DHEA on Skin Aging - Placebo-Controlled and Randomized Phase III Study in Postmenopausal Women.[NCT00248989] | Phase 3 | 150 participants (Actual) | Interventional | 2004-11-01 | Completed | ||
| Phase II-III Placebo-Controlled, Study to Evaluate the Effects of DHEA on Vasomotor Symptoms (Hot Flashes) in Postmenopausal Women[NCT00317148] | Phase 2/Phase 3 | 50 participants (Actual) | Interventional | 2005-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for dehydroepiandrosterone and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Current concepts in bone and reproductive health in adolescents with anorexia nervosa.
Topics: Adolescent; Anorexia Nervosa; Bone Density; Bone Density Conservation Agents; Bone Diseases; Bone Re | 2008 |
6 other studies available for dehydroepiandrosterone and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Metastasin S100A4 is a mediator of sex hormone-dependent formation of the cortical bone.
Topics: Animals; Bone Density; Bone Resorption; Dehydroepiandrosterone; Estrogens; Female; Femur; Mice; Mice | 2013 |
Dehydroepiandrosterone inhibited the bone resorption through the upregulation of OPG/RANKL.
Topics: Adjuvants, Immunologic; Animals; Animals, Newborn; Bone Resorption; Carrier Proteins; Cells, Culture | 2006 |
Anabolic effects of insulin on bone suggest a role for chromium picolinate in preservation of bone density.
Topics: Animals; Bone Density; Bone Resorption; Calcium; Collagen; Dehydroepiandrosterone; Dehydroepiandrost | 1995 |
Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.
Topics: Aged; Atrophy; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Dehydroep | 1997 |
Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.
Topics: Aged; Atrophy; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Dehydroep | 1997 |
Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.
Topics: Aged; Atrophy; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Dehydroep | 1997 |
Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.
Topics: Aged; Atrophy; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Dehydroep | 1997 |
The prevention of osteoporotic progression by means of steroid loaded TCPL drug delivery systems.
Topics: Animals; Bone Resorption; Calcium Phosphates; Dehydroepiandrosterone; Diosgenin; Disease Progression | 2001 |
Persistence of increased bone resorption and possible role of dehydroepiandrosterone as a bone metabolism determinant in osteoporotic women in late post-menopause.
Topics: Age Factors; Aged; Aged, 80 and over; Bone and Bones; Bone Resorption; Dehydroepiandrosterone; Femal | 1989 |